Activation of Notch-1 signaling pathway in macrophages to secrete PD-L1 and regulate cytotoxicity of CAR-T cells in diffuse large B-cell lymphoma

被引:0
|
作者
Li, Weijing [1 ]
Wu, Lili [1 ]
Huang, Chen [1 ]
Ma, Hongqing [2 ]
Wang, Lianjing [1 ]
Liu, Wei [1 ]
Liu, Lihong [1 ]
机构
[1] Hebei Med Univ, Dept Hematol, Hosp 4, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Dept Gen Surg, Hosp 4, Shijiazhuang, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 02期
关键词
diffuse large B-cell lymphoma; macrophages; Notch-1/IRE1/XBP1s signaling pathway; PD-L1; CAR-T cells; UNFOLDED PROTEIN RESPONSE; CHECKPOINT BLOCKADE; EXPRESSION; IMMUNITY;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: To investigate the mechanism of action of the Notch-1/IRE1/XBP1s signaling pathway in diffuse large B -cell lymphoma (DLBCL). Methods: The expressions of relevant proteins were detected by Western blotting. The effect of myeloidspecific knockout of Notch -1 on lymphoma progression was observed by mouse tumor transplantation and imaging. The apoptosis of chimeric antigen receptor T -cell therapy (CAR -T) cells were detected by flow cytometry, and the proliferation of CAR -T cells was detected by wound healing assay and cell counting kit -8 (CCK8) assay. Results: Lymphoma cells mediated the Notch -1 signaling pathway in bone marrow -derived macrophages and promoted the activation of STAT3 and STAT6 in bone marrow -derived macrophages. Myeloid -specific knockout of Notch -1 could inhibit the progression of lymphoma. Lymphoma cells enhanced the expression of p -PERK, p-IRE1 alpha, ATF6, IL -6, IL -4, p-AKT, CD9, CD63 and PD -L1 in bone marrow -derived macrophages by mediating the Notch -1 signaling pathway. Knockout of Notch -1 in macrophages alleviated, to some extent, the suppression of killing activity of CAR -T cells, while activation of Notch -1 in macrophages inhibited proliferation and promoted apoptosis of CAR -T cells. The PD -L1 antibody significantly restored the cytotoxicity and proliferation of CAR -T cells, and inhibited their apoptosis. Conclusion: Activation of the Notch-1/IRE1/XBP1s signaling pathway in myeloid macrophages promotes the secretion of IL -6 and IL -4 as well as PD -L1, thereby inhibiting the activity and proliferation of CAR -T cells and promoting their apoptosis.
引用
收藏
页码:1845 / 1859
页数:15
相关论文
共 50 条
  • [31] The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma
    Zhao, Jinrong
    Wei, Chong
    Wang, Shuqing
    Zhang, Yan
    Wang, Wei
    Zhao, Danqing
    Wang, Zi
    Zhou, Zhipeng
    Bai, Jing
    Zhang, Wei
    Zhou, Daobin
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [32] The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma
    Jinrong Zhao
    Chong Wei
    Shuqing Wang
    Yan Zhang
    Wei Wang
    Danqing Zhao
    Zi Wang
    Zhipeng Zhou
    Jing Bai
    Wei Zhang
    Daobin Zhou
    Blood Cancer Journal, 13
  • [33] LncRNA NEAT1 regulate diffuse large B-cell lymphoma by targeting miR-495-3p/PD-L1 axis
    Yuan, Jun
    Yang, Jie
    Wang, Ruicang
    Hao, Hongling
    Li, Jie
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (03) : 429 - 436
  • [34] Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
    Hirayama, Alexandre Vinaud
    Fiorenza, Salvatore
    Gauthier, Jordan
    Voutsinas, Jenna M.
    Wu, Qian Vicky
    Kimble, Erik L.
    Pender, Barbara S.
    Kirchmeier, Delaney R.
    Di, Henna A.
    Cassaday, Ryan D.
    Chapuis, Aude G.
    Green, Damian J.
    Kiem, Hans-Peter
    Milano, Filippo
    Shadman, Mazyar
    Till, Brian G.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2022, 140 : 7447 - 7449
  • [35] Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma
    Cai, Yiqing
    Chen, Xiaomin
    Lu, Tiange
    Fang, Xiaosheng
    Ding, Mengfei
    Yu, Zhuoya
    Hu, Shunfeng
    Liu, Jiarui
    Zhou, Xiangxiang
    Wang, Xin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (14): : 4627 - 4643
  • [36] Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
    Georgiou, Konstantinos
    Chen, Longyun
    Berglund, Mattias
    Ren, Weicheng
    de Miranda, Noel F. C. C.
    Lisboa, Susana
    Fangazio, Marco
    Zhu, Shida
    Hou, Yong
    Wu, Kui
    Fang, Wenfeng
    Wang, Xianhuo
    Meng, Bin
    Zhang, Li
    Zeng, Yixin
    Bhagat, Govind
    Nordenskjold, Magnus
    Sundstrom, Christer
    Enblad, Gunilla
    Dalla-Favera, Riccardo
    Zhang, Huilai
    Teixeira, Manuel R.
    Pasqualucci, Laura
    Peng, Roujun
    Pan-Hammarstrom, Qiang
    BLOOD, 2016, 127 (24) : 3026 - 3034
  • [38] PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype
    Godfrey, James
    Tumuluru, Sravya
    Bao, Riyue
    Leukam, Michael
    Venkataraman, Girish
    Phillip, John
    Fitzpatrick, Carrie
    McElherne, James
    MacNabb, Brendan W.
    Orlowski, Robert
    Smith, Sonali M.
    Kline, Justin
    BLOOD, 2019, 133 (21) : 2279 - 2290
  • [39] EBV plus Diffuse Large B-Cell Lymphoma, NOS Shows Over-Expression of PD-L1/PD-1
    Jagannathan, Geetha
    Gong, Jerald
    Uppal, Guldeep
    MODERN PATHOLOGY, 2018, 31 : 525 - 525
  • [40] EBV plus Diffuse Large B-Cell Lymphoma, NOS Shows Over-Expression of PD-L1/PD-1
    Jagannathan, Geetha
    Gong, Jerald
    Uppal, Guldeep
    LABORATORY INVESTIGATION, 2018, 98 : 525 - 525